clotrimazole has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, P | 1 |
| Yang, X | 1 |
| Yin, Q | 1 |
| Yi, J | 1 |
| Shen, W | 1 |
| Zhao, L | 1 |
| Zhu, Z | 1 |
| Liu, J | 1 |
1 other study available for clotrimazole and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Clotrimazole; Epithelial-Mesench | 2016 |